{"id":68,"date":"2023-03-30T14:11:57","date_gmt":"2023-03-30T13:11:57","guid":{"rendered":"http:\/\/molecularhealth.com\/eu\/?page_id=68"},"modified":"2026-02-11T14:15:51","modified_gmt":"2026-02-11T14:15:51","slug":"resources","status":"publish","type":"page","link":"https:\/\/molecularhealth.com\/eu\/resources\/","title":{"rendered":"Resources"},"content":{"rendered":"<div class=\"lazyblock-mh-hero-banner-NaDeO alignfull alignfull  wp-block-lazyblock-mh-hero-banner\"><!-- Hero Banner -->\r\n<div class=\"mh-hero-banner  dm-lazyblock-mh-hero-banner-NaDeO\" style=\"background:url(https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/Resources_Hero.jpg) center center no-repeat; background-size: cover;\">\r\n        <div class=\"mh-hero-content\">\r\n            <div class=\"mh-hero-content-block-1\">\r\n              <span class=\"block-1-wrap\">\r\n                <div class=\"mh-hero-heading\">\r\n                        <h1>                            Resources                            <br>Browse our materials                            <br>for additional information                        \r\n                        <\/h1>\r\n                    <\/div>\r\n                \r\n                        <div class=\"mh-hero-links\"><a class=\"tileButton\" href=\"http:\/\/molecularhealth.com\/eu\/contact\/\" target=\"_self\"><i data-feather=\"arrow-right\"><\/i> <span>Contact us<\/span><\/a><\/div>              <\/span>\r\n            <\/div>\r\n\r\n            \r\n        <\/div>\r\n<\/div>\r\n<\/div>\n\n\n<p>The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more. <br>If you can&#8217;t find something, <a href=\"http:\/\/molecularhealth.com\/eu\/contact\/\" data-type=\"page\" data-id=\"72\">please let us know<\/a> and we&#8217;ll reach out to you as soon as we can.<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\">\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:75%\"><div class=\"lazyblock-mh-resources-posts-2iq12l wp-block-lazyblock-mh-resources-posts\"><div class=\"mh-filter-result\">\r\n    \r\n            <ul class=\"project-tiles\">\r\n            <li><h4>Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline \u2013 relevance for additional therapeutic options<\/h4><div class=\"subline\">Harb, N et al. Cancer Genetics 2026<\/div><span><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S221077622600044X\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>MH Connector<\/h4><div class=\"subline\">MH Connector &#8211; your step towards an end-to-end, multi-modal data workflow within your existing NGS tumor profiling<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/MH-25-019-1_MH_Connector_Flyer.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>Dataome-powered Precision Medicine<\/h4><div class=\"subline\">the bioRN Life Science Cluster magazine &#8211; The Heidelberg Ecosystem has it all (for MH&#8217;s contribution see page 8)<\/div><span><a href=\"https:\/\/issuu.com\/biocom\/docs\/eb_2025_autumn_biorn_life_2025?fr=sNTI4OTgzNTg2MzQ\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Malignant Melanoma: Landscape of Molecular Markers<\/h4><div class=\"subline\">Winter, M et al. Biomedicines 2026<\/div><span><a href=\"https:\/\/doi.org\/10.3390\/biomedicines14010157\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Molecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions<\/h4><div class=\"subline\">Winter, M et al. Cancers 2026<\/div><span><a href=\"https:\/\/doi.org\/10.3390\/cancers18020216\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-and-axxam-enter-into-a-strategic-partnership-to-bolster-the-discovery-of-innovative-targets-in-drug-development\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>MH Guide \u2013 Discover the benefits of automated clinical variant interpretation for your molecular tumor profiling<\/h4><div class=\"subline\">MH Guide interprets complex genetic data quickly and accurately to meet the growing challenges of sequence variant interpretation today and tomorrow.<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/MH-23-019-3EN_MH_Guide_Pathology.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>MH Guide as IVDR-certified product and part of your complete solution for NGS-based molecular tumor profiling<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/wp-content\/uploads\/sites\/2\/MH-22-022-3EN_MH-Guide-IVDR-Flyer.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>MH Guide \u2013 Data security &amp; Data privacy<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/MH-24-003-2_MH_Guide_Data_Security_and_Privacy.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>MH Guide for hereditary cancers \u2013 Genetic testing for predisposition to cancer<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/MH-24-008-1EN_MH_Guide_hereditary_cancer.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>MH Guide\/Mendel \u2013 NGS-tertiary analysis for predisposition to hereditary cancers and inherited diseases<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/MH-24-040-1_MH_Guide_Mendel_brochure.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-Mitte<\/h4><div class=\"subline\">Tsibulak, Irina et al. International Journal of Gynecological Cancer. 2025; 35(2):100054. doi: 10.1016\/j.ijgc.2024.100054<\/div><span><a href=\"https:\/\/www.international-journal-of-gynecological-cancer.com\/article\/S1048-891X(24)04617-6\/fulltext\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach<\/h4><div class=\"subline\">Mustea, A et al. J Cancer Res Clin Oncol. 2024; 150(7):367. https:\/\/doi.org\/10.1007\/s00432-024-05901-4<\/div><span><a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05901-4\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Integrated DNA Technologies and Molecular Health Ink Commercial Partnership<\/h4><div class=\"subline\">Strategic partnership enables companies to combine technology offerings and streamline NGS workflows <\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/integrated-dna-technologies-and-molecular-health-ink-commercial-partnership\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for\u00a0APC<\/h4><div class=\"subline\">Schell, MJ et al. Nat Commun. 2016; 7:11743. doi: 10.1038\/ncomms11743<\/div><span><a href=\"https:\/\/www.nature.com\/articles\/ncomms11743\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer<\/h4><div class=\"subline\">Malgerud, L. et al. Mol Oncol. 2017; 11(10):1413-1429. doi: 10.1002\/1878-0261.12108<\/div><span><a href=\"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/1878-0261.12108\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Consolidated BRCA1\/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide<\/h4><div class=\"subline\">Hirotsu, Y. et al. Int J Mol Sci. 2020; 21(11):3895. doi: 10.3390\/ijms21113895<\/div><span><a href=\"https:\/\/www.mdpi.com\/1422-0067\/21\/11\/3895\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>MH catalogue of peer-reviewed studies 2009 &#8211; 2026<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/wp-content\/uploads\/sites\/2\/MH-24-001-4_MH_Study_Brochure.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>St. Marianna University School of Medicine in Japan relies on MH Guide for personalized cancer medicine<\/h4><div class=\"subline\">Press release, October 27, 2023<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/st-marianna-university-school-of-medicine-in-japan-relies-on-mh-guide-for-personalized-cancermedicine\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Molecular Health and Takara Bio collaborate to support Genome Medicine in Japan<\/h4><div class=\"subline\">Press release, October 13, 2023<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-and-takara-bio-collaborate-to-support-genome-medicine-in-japan\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer \u2013 A Feasibility Study<\/h4><div class=\"subline\">Jaeger, BAS. Geburtshilfe Frauenheilkd. 2023; 83(9):1138-1147. doi: 10.1055\/a-2150-9440<\/div><span><a href=\"https:\/\/www.thieme-connect.com\/products\/ejournals\/abstract\/10.1055\/a-2150-9440\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Analysis and Clinical Relevance of Tumor Mutational Burden<\/h4><div class=\"subline\">A description of TMB as potential biomarker.<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/analysis-and-clinical-relevance-of-tumor-mutational-burden\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3)<\/h4><div class=\"subline\">Jackson, D.B. et al. Pharmaceutics. 2023; 15(6), 1673. doi: 10.3390\/pharmaceutics15061673<\/div><span><a href=\"https:\/\/doi.org\/10.3390\/pharmaceutics15061673\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide<\/h4><div class=\"subline\">Mustea, A. et al. Cancers. 2023; 15(7). doi: 10.3390\/cancers15072053<\/div><span><a href=\"https:\/\/doi.org\/10.3390\/cancers15072053\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Currently no job listings<\/h4><div class=\"subline\"><\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/currently-no-job-listings\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms<\/h4><div class=\"subline\">Brock, S. et al. Front. Mol. Med. 2023; 2:1035290. https:\/\/doi.org\/10.3389\/fmmed.2022.1035290<\/div><span><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2022.1035290\/full\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Daten t\u00f6ten. Den Krebs.<\/h4><div class=\"subline\">An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)<\/div><span><a href=\"https:\/\/molecularhealth.com\/wp-content\/uploads\/sites\/2\/Focus2023_FVB_article.pdf\" target=\"_blank\" download>Download article<\/a><\/span><\/li><li><h4>Molecular Health receives IVDR certification for MH Guide<\/h4><div class=\"subline\">Press release, 13 July 2022<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-receives-ivdr-certification-for-mh-guide\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions<\/h4><div class=\"subline\">Press release, 10 March 2022<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-and-collaborators-prove-new-analytical-approach-that-leverages-real-world-data-to-anticipate-molecular-causation-of-adverse-drug-reactions\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Advancing drug safety science by integrating molecular knowledge with post\u2010marketing adverse event reports<\/h4><div class=\"subline\">Soldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022; 11(5):540-555. doi: 10.1002\/psp4.12765<\/div><span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35143713\/\" target=\"_self\">Open resource<\/a><\/span><\/li><li><h4>Evaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics<\/h4><div class=\"subline\">Heydt, C. et al. J. Mol. Pathol. 2022; 3(1), 53-67; https:\/\/doi.org\/10.3390\/jmp3010006<\/div><span><a href=\"https:\/\/www.mdpi.com\/2673-5261\/3\/1\/6\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors<\/h4><div class=\"subline\">Kim, S. et al. Clin Transl Sci. 2022; 15(6):1430-1438. doi: 10.1111\/cts.13254<\/div><span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35191192\/\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>The COVID-19 explorer \u2013 An integrated, whole patient knowledge model of COVID-19 disease<\/h4><div class=\"subline\">Brock, S. et al. Front. Mol. Med. 2022; 2:1035215. https:\/\/doi.org\/10.3389\/fmmed.2022.1035215<\/div><span><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2022.1035215\/full\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey<\/h4><div class=\"subline\">Press release, 19. October 2021<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-and-gen-era-diagnostics-agree-to-collaborate-in-the-field-of-precision-oncology-in-turkey\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Molecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patients<\/h4><div class=\"subline\">Press release, 9 August 2021<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-and-essen-university-hospital-launch-collaborative-project-to-improve-care-for-covid-19-patients\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Konyang University Hospital in South Korea relies on MH Guide for personalized cancer medicine<\/h4><div class=\"subline\">Press release, 16 July 2021<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/konyang-university-hospital-in-south-korea-relies-on-mh-guide-for-personalized-cancer-medicine\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Wir bringen die biologische Grammatik in die Medizin<\/h4><div class=\"subline\">Plattform Life Sciences &#8220;Smarte Medizin&#8221; \u2013 Interview with Friedrich von Bohlen (in German)<\/div><span><a href=\"https:\/\/www.goingpublic.de\/wp-content\/uploads\/epaper\/2021_2_LS\/#10\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Target adverse event profiles for predictive safety in the postmarket setting<\/h4><div class=\"subline\">Peter Schotland, Rebecca Racz, David B. Jackson, Theodoros G. Soldatos, Robert Levin, David G. Strauss and Keith Burkhart. Clinical Pharmacology &amp; Therapeutics. 2021; 109(5):1232. doi: 10.1002\/cpt.2074<\/div><span><a href=\"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.2074\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>MH Guide: Molecular tumor diagnostics in 7 steps<\/h4><div class=\"subline\">An overview of the MH Guide workflow from hotspot to gene profile<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/mh-guide-molecular-tumor-diagnostics-in-7-steps\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Panel diagnostics instead of hotspot? Here are the differences<\/h4><div class=\"subline\">An overview of the pros and cons of using NGS-based panels for molecular tumor profiling<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/panel-diagnostics-instead-of-hotspot-here-are-the-differences\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Molecular Health \u2013 intelligent solutions for smarter healthcare<\/h4><div class=\"subline\">NATURE BiopharmaDealmakers<\/div><span><a href=\"https:\/\/www.nature.com\/articles\/d43747-021-00030-0\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>70-year-old with recurrent ovarian cancer<\/h4><div class=\"subline\">The story of new hope for an ovarian cancer patient thanks to MH Guide.<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/70-year-old-with-recurrent-ovarian-cancer\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>MH Guide: six questions and answers<\/h4><div class=\"subline\">A list of answers to commonly asked questions about tertiary analysis solutions like MH Guide.<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/mh-guide-six-questions-and-answers\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Molecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide\/BRCA and MH Guide\/Mendel<\/h4><div class=\"subline\">Press release, 2 March 2021<\/div><span><a href=\"https:\/\/molecularhealth.com\/eu\/molecular-health-and-falco-biosystems-team-up-to-provide-genetic-analysis-services-using-mh-guide-brca-and-mh-guide-mendel\/\" target=\"_self\">Read more<\/a><\/span><\/li><li><h4>Molekulare Diagnostik beim Mammakarzinom \u2013 Wo stehen wir auf dem Weg zur molekular stratifizierten Therapie?<\/h4><div class=\"subline\">\u00c4rzteZeitung \u2013 SpringerMedizin (in German)<\/div><span><a href=\"https:\/\/www.aerztezeitung.de\/Nachrichten\/Wo-stehen-wir-auf-dem-Weg-zur-molekular-stratifizierten-Therapie-417742.html\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Datenprojekt zu Covid-Langzeitfolgen startet<\/h4><div class=\"subline\">Handelsblatt (in German)<\/div><span><a href=\"https:\/\/www.handelsblatt.com\/inside\/digital_health\/friedrich-von-bohlen-datenprojekt-zu-covid-langzeitfolgen-startet\/26948880.html\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>Wie der MH Corona Explorer die Versorgung COVID-19-Kranker verbessern soll<\/h4><div class=\"subline\">\u00c4rzteZeitung (in German)<\/div><span><a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/Wie-der-MH-Corona-Explorer-die-Versorgung-COVID-19-Kranker-verbessern-soll-417310.html\" target=\"_blank\">Open resource<\/a><\/span><\/li><li><h4>A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development<\/h4><div class=\"subline\">Kim, S. et al. Clin Transl Sci. 2022; 15(4):1003-1013. doi: 10.1111\/cts.13219<\/div><span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35014203\/\" target=\"_blank\">Open resource<\/a><\/span><\/li>        <\/ul>\r\n            \r\n<\/div><\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more. If you can&#8217;t find something, please let us know and we&#8217;ll reach out to you as soon as we can.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":6000,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":""},"class_list":["post-68","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/68","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/comments?post=68"}],"version-history":[{"count":40,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/68\/revisions"}],"predecessor-version":[{"id":4296,"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/pages\/68\/revisions\/4296"}],"wp:attachment":[{"href":"https:\/\/molecularhealth.com\/eu\/wp-json\/wp\/v2\/media?parent=68"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}